The case fatality rate for patients with COVID-19 and CVD is higher than for cancer, chronic respiratory disease, and diabetes. Here is current guidance from the ACC.
The reported case fatality rate for patients with COVID-19 infection who have underlying cardiovascular disease (CVD) is approximately 10% -- higher than for cancer, chronic respiratory disease, and diabetes. The American College of Cardiology recently published a clinical bulletin titled "COVID-19 Clinical Guidance for the CV Care Team." The majority of the information is also highly relevant for primary care physicians who routinely see patients with a full range of CVD and related morbidity.Click through the short slide show below for a summary of the bulletin curated for primary care.
Related Content:Cardiovascular Disease